Results

Total Results: 2,920 records

Showing results for "improvements".

181. Pediatric Quality Measures Program 3.0: An Evidence Map of Measures for Vision, Hearing, and Developmental Screening and Followup | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/pqmp/protocol
     August 01, 2024 - Have any of these studies shown improvements in quality of care, improvements in health outcomes, or … ] OR “process measure”[tiab] OR “process measures”[tiab] OR “quality improvement”[tiab] OR “quality improvements

182. What is the comparative effectiveness of conventional CT, MDCT (including “virtual CT bronchoscopy”), PET/PET-CT, and MRI for the diagnosis or pretreatment staging of small cell and non-small cell lung cancer? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-conventional-ct-mdct-including-virtual-ct-bronchoscopy-petpet-ct-and-mri-for-the-diagnosis-or-pretreatment-staging-of-small-cell-and-non-small-cell-lung-cancer
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

183. 1. Does mass spectrometric analysis and therapeutic monitoring of tacrolimus as compared with immunoassay analysis and therapeutic monitoring produce a) better organ survival rate, b) fewer rejections, c) less nephrotoxicity and/or d) cost… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-does-mass-spectrometric-analysis-and-therapeutic-monitoring-of-tacrolimus-as-compared-with-immunoassay-analysis-and-therapeutic-monitoring-produce-a-better-organ-survival-rate-b-fewer-rejections-c-less-nephrotoxicity-andor
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

184. Description of a question or questions about a health care test or treatment: o In women with leiomyomas who are candidates for surgery, does the use of adjunctive medical treatment result in better outcomes? (Preoperative adjuvants &… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/description-of-a-question-or-questions-about-a-health-care-test-or-treatment-o-in-women-with-leiomyomas-who-are-candidates-for-surgery-does-the-use-of-adjunctive-medical-treatment-result-in-better-outcomes-preoperative-adjuv
     November 01, 2017 - For example, improvements in symptoms or problems with diagnosis.

185. What evidence exists for programs to increase patient adherence to prescription medications? Which programs/approaches are most effective at increasing adherence for which populations and conditions? If little or no evidence exists, can… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-evidence-exists-for-programs-to-increase-patient-adherence-to-prescription-medications-which-programsapproaches-are-most-effective-at-increasing-adherence-for-which-populations-and-conditions-if-little-or-no-evidence-ex
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

186. For patients with PKU, there is now a pharmaceutical drug to treat this condition. In the past is was treated by medical foods that eliminated the harmful substance phenylalanine. The cost of the new drug is $70K year. The cost to treat… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-t
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

187. Diagnosis and treatment of low back pain:Key questions:In patients with low back pain, what are the benefits and harms of identifying risk factors for chronicity and targeting treatment based on assessed… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-low-back-painbr-key-questionsbr-olliin-patients-with-low-back-pain-what-are-the-benefits-and-harms-of-identifying-risk-factors-for-chronicity-and-targeting-treatment-based-on-assessed-riskliliin-pa
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

188. What are the best practice Behavioral Health programs for type 1 diabetes, type 2 diabetes and gestational diabetes. Does educational counseling help paitients improve control and adherence to treatment? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-are-the-best-practice-behavioral-health-programs-for-type-1-diabetes-type-2-diabetes-and-gestational-diabetes-does-educational-counseling-help-paitients-improve-control-and-adherence-to-treatment
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

189. For patients with Crohn's disease, what treatments or therapies, alone or in conjunction with one another, provide the highest rate of disease management with the lowest risk of long term complications, particularly in young women? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-wome
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

190. Mindfulness meditation encompasses a range of meditation techniques that have been increasingly used to treat behavioral disorders, especially those associated with stress. Some of these were previously described in AHRQ Publication No.… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/mindfulness-meditation-encompasses-a-range-of-meditation-techniques-that-have-been-increasingly-used-to-treat-behavioral-disorders-especially-those-associated-with-stress-some-of-these-were-previously-described-in-ahrq-publi
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

191. 1. What are the benefits and harms of rhythm control compared to rate control (including newer agents) ? What are the benefits and harms of strict vs more lenient rate control? 2. What are the benefits and harms of different… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-what-are-the-benefits-and-harms-of-rhythm-control-compared-to-rate-control-including-newer-agents-what-are-the-benefits-and-harms-of-strict-vs-more-lenient-rate-control-2-what-are-the-benefits-and-harms-of-different-antico
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)  

192. How can patients who have chronic diseases better prepare for critical illness and the end of life? Will a decision aid, using individualized estimates of outcomes, help shared decision making about advance care planning? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/how-can-patients-who-have-chronic-diseases-better-prepare-for-critical-illness-and-the-end-of-life-will-a-decision-aid-using-individualized-estimates-of-outcomes-help-shared-decision-making-about-advance-care-planning
     November 01, 2017 - (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

193. Machine-Learning-Tools-Appendix-D (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-d.xlsx
     January 01, 2024 - Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements … Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements … Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements … Whilst promising, the percentage of correct responses is still unsatisfactory and therefore substantial improvements

194. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - biologic   DMARDs:  Better  improvements  in  disease   activity  from  combination … Patients with moderate RA had significant improvements and better overall functional status than those … with severe RA, but those with severe RA had the greatest improvements from baseline in disease activity … Patients with moderate RA had significant improvements and better overall functional status than those … with severe RA, but those with severe RA had the greatest improvements from baseline in disease activity

195. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - biologic   DMARDs:  Better  improvements  in  disease   activity  from  combination … Patients with moderate RA had significant improvements and better overall functional status than those … with severe RA, but those with severe RA had the greatest improvements from baseline in disease activity … Patients with moderate RA had significant improvements and better overall functional status than those … with severe RA, but those with severe RA had the greatest improvements from baseline in disease activity

196. Telehealth: Mapping the Evidence for Patient Outcomes From Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/telehealth/technical-brief
     January 01, 2020 - counseling or remote monitoring in chronic conditions such as cardiovascular and respiratory disease, with improvements

197. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/asthma-nonpharmacologic-treatment/thermoplasty-systematic-review
     October 01, 2019 - The sham-controlled, blinded study found modest improvements in severe exacerbations and significantly

198. Diagnosis and Treatment of Clinical Alzheimer's-Type Dementia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/alzheimers-type-dementia/research
     October 01, 2022 - Regardless of CATD severity, cholinesterase-inhibitors produced small improvements in cognition and function

199. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Have improvements in intermediate outcomes (SVR, histologic changes) been shown to reduce the risk or … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic changes … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic changes) … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic changes) … Key Question 4: Have improvements in intermediate outcomes been shown to reduce risk or rates of adverse

200. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Have improvements in intermediate outcomes (SVR, histologic changes) been shown to reduce the risk or … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic changes … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic changes) … KQ 4: Have improvements in intermediate outcomes (viremia, liver function tests, histologic changes) … Key Question 4: Have improvements in intermediate outcomes been shown to reduce risk or rates of adverse